HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Hirudin Therapy

Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Thrombolytic Therapy: 8675
    - Hirudin Therapy: 7

Experts

1.	Rosario-Collazo, J: 1 article (12/2001)
2.	Skelton, H: 1 article (12/2001)
3.	Smith, K J: 1 article (12/2001)
4.	Anand, S S: 1 article (02/2001)
5.	Eikelboom, J W: 1 article (02/2001)
6.	Mehta, S R: 1 article (02/2001)
7.	Weitz, J I: 1 article (02/2001)
8.	Yi, C: 1 article (02/2001)
9.	Yusuf, S: 1 article (02/2001)
10.	Askenase, A: 1 article (01/2000)

Related Diseases

1.	Thrombocytopenia (Thrombopenia) 12/01/2001 - "We describe a patient with a history of type II heparin-induced thrombocytopenia who was placed on intravenous hirudin therapy. " 02/06/2001 - "Unfractionated heparin is a recognized cause of thrombocytopenia, but the incidence, predictors, and prognostic significance of thrombocytopenia during hirudin therapy in ACS have not been reported. " 01/01/2000 - "Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia." 08/01/1993 - "Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis."
2.	Venous Thrombosis (Deep-Vein Thrombosis) 01/01/2000 - "Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia." 08/01/1993 - "Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis."
3.	Hemorrhage 12/01/1996 - "There were no significant differences in the incidence of serious or life-threatening bleeding complications, but hirudin therapy was associated with a higher incidence of moderate bleeding (8.8 percent vs. 7.7 percent, P = 0.03). " 05/01/1992 - "The correction of the above abnormalities and related bleeding indicate it beneficial to use hirudin therapy in secondary coagulopathies and circulatory decompensation."
4.	Myocardial Infarction 12/01/1996 - "At 24 hours, the risk of death or myocardial infarction was significantly lower in the group assigned to hirudin therapy than in the group assigned to heparin (1.3 percent vs. 2.1 percent, P = 0.001). "
5.	Glaucoma 03/01/1969 - "[The effect of hirudin therapy on certain functions and hydrodynamics of the eye in patients with glaucoma]."

Related Drugs and Biologics

1.	Heparin (Liquaemin)